Related Experiment Video
Updated: May 10, 2026

Immobilization of Multi-biocatalysts in Alginate Beads for Cofactor Regeneration and Improved Reusability
Published on: April 22, 2016
Nicotinic acid production from 3-methylpyridine by E. coli whole-cell biocatalyst
Sineenat Sripattanakul1, Piyasiri Chueakwon2, Le Thi Thuy Trinh2
1School of Chemistry, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand; Office of Research Administration, Chiang Mai University, Chiang Mai 50200, Thailand.
Abstract:
Nicotinic acid, a bioactive form of niacin (vitamin B3), is an essential nutrient involved in various metabolic pathways. Its deficiency can lead to severe health issues, emphasizing the need for effective production methods. Traditional chemical methods for synthesizing nicotinic acid often require harsh reaction conditions and produce environmentally hazardous byproducts. This has prompted increasing interest in more sustainable biocatalytic alternatives. In this study, we investigated the bioconversion of 3-methylpyridine (3-MP) to nicotinic acid using resting cells of recombinant Escherichia coli expressing enzymes from Pseudomonas putida mt-2. Through systematic optimization, E. coli MG1655 RARE cells co-overexpressing xylene monooxygenase (XMO: XylM and its reductase XylA) and benzyl alcohol dehydrogenase (XylB) achieved efficient biotransformation of 9 mM 3-MP to 8.28 ± 0.35 mM nicotinic acid within 12 hours, corresponding to a yield of 92.0 % ± 3.9 %. This work presents a streamlined biocatalytic route for nicotinic acid synthesis and offers a foundation for further metabolic engineering of microbial production systems.
Related Concept Videos
Products of the Citric Acid Cycle
Biosynthesis in Bacteria
Production of Organic Acids
Production of Antibiotics
Production of Pharmaceuticals

